No Data
No Data
Wuxi Apptec (02359.HK) received a shareholding of 1,927,400 shares from JPMorgan.
According to the latest equity disclosure information from the Hong Kong Stock Exchange on June 6th, 2024, Wuxi Apptec (02359.HK) received an increase in shareholding of 1,927,400 shares from JPMorgan Chase & Co. at an average price of HKD 34.8647 per share, involving approximately HKD 67.1993 million. After the increase, the latest number of shares held by JPMorgan Chase & Co. is 35,525,040 shares, and the proportion of shares held increased from 8.67% to 9.17%.
Express News | JPMorgan Chase & Co's Long Position in H-Shares of WuXi AppTec Increases to 9.17% on May 30 From 8.67%- HKEX
Express News | Fitch Ratings Places Wuxi Apptec's 'bbb' Ratings on Rating Watch Negative
Fitch: Affected by the draft US Biosafety Law, Pharmacovigilance (2359.HK/603259.SH) BBB rating entered the watch list
On May 31, Fitch added the BBB rating and advanced unsecured rating of the long-term issuer of Kangde Pharmaceutical to the watch list. Fitch said the draft US Biosafety Act exposed Pharmacovigilance's credit status to potentially increased regulatory risks and uncertainties. It was also pointed out that the relevant plan is still in the process of legislative review and is subject to further review and revision. After the final provisions and implementation measures of the Biosafety Law were clarified, the Pharmacovigant Rating was removed from the watch list, and the impact of the aforementioned law on its credit was assessed. It is worth noting that among Fitch companies, the company that is currently closest to Kangde Pharmaceutical is Charles River (C)
Changes in Hong Kong stocks | CRO concept stocks picked up in early trading, and many companies began to adjust their business in the US. Institutions say industry demand is expected to recover in the second half of the year
CRO concept stocks picked up in early trading. As of press release, Viva Biotech (01873) rose 3.13% to HK$0.66; Kanglong Chemical (03759) rose 2.82% to HK$9.86; Pharmaceutical Biotech (02269) rose 2.68% to HK$11.5; and Pharmaceuticals (02359) rose 2.31% to HK$35.45.
WuXi AppTec Insider Lowered Holding By 15% During Last Year
From what we can see, insiders were net sellers in WuXi AppTec Co., Ltd.'s (SHSE:603259 ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it. Whil
No Data